nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentostatin—Nucleic Acid Synthesis Inhibitors—Azathioprine—systemic scleroderma	0.874	1	CiPCiCtD
Pentostatin—Pruritus—Captopril—systemic scleroderma	8.76e-05	0.000694	CcSEcCtD
Pentostatin—Paraesthesia—Mycophenolic acid—systemic scleroderma	8.74e-05	0.000692	CcSEcCtD
Pentostatin—Pain—Leflunomide—systemic scleroderma	8.73e-05	0.000691	CcSEcCtD
Pentostatin—Constipation—Leflunomide—systemic scleroderma	8.73e-05	0.000691	CcSEcCtD
Pentostatin—Infection—Lisinopril—systemic scleroderma	8.71e-05	0.00069	CcSEcCtD
Pentostatin—Anaemia—Mycophenolate mofetil—systemic scleroderma	8.7e-05	0.000689	CcSEcCtD
Pentostatin—Dyspnoea—Mycophenolic acid—systemic scleroderma	8.68e-05	0.000688	CcSEcCtD
Pentostatin—Somnolence—Mycophenolic acid—systemic scleroderma	8.66e-05	0.000686	CcSEcCtD
Pentostatin—Agitation—Mycophenolate mofetil—systemic scleroderma	8.65e-05	0.000685	CcSEcCtD
Pentostatin—Shock—Lisinopril—systemic scleroderma	8.63e-05	0.000683	CcSEcCtD
Pentostatin—Thrombocytopenia—Lisinopril—systemic scleroderma	8.59e-05	0.00068	CcSEcCtD
Pentostatin—Dyspepsia—Mycophenolic acid—systemic scleroderma	8.57e-05	0.000679	CcSEcCtD
Pentostatin—Tachycardia—Lisinopril—systemic scleroderma	8.56e-05	0.000678	CcSEcCtD
Pentostatin—Body temperature increased—Azathioprine—systemic scleroderma	8.54e-05	0.000677	CcSEcCtD
Pentostatin—Abdominal pain—Azathioprine—systemic scleroderma	8.54e-05	0.000677	CcSEcCtD
Pentostatin—Skin disorder—Lisinopril—systemic scleroderma	8.52e-05	0.000675	CcSEcCtD
Pentostatin—Hyperhidrosis—Lisinopril—systemic scleroderma	8.48e-05	0.000672	CcSEcCtD
Pentostatin—Diarrhoea—Captopril—systemic scleroderma	8.47e-05	0.000671	CcSEcCtD
Pentostatin—Decreased appetite—Mycophenolic acid—systemic scleroderma	8.46e-05	0.00067	CcSEcCtD
Pentostatin—Vertigo—Mycophenolate mofetil—systemic scleroderma	8.46e-05	0.00067	CcSEcCtD
Pentostatin—Syncope—Mycophenolate mofetil—systemic scleroderma	8.44e-05	0.000669	CcSEcCtD
Pentostatin—Erectile dysfunction—Prednisone—systemic scleroderma	8.44e-05	0.000668	CcSEcCtD
Pentostatin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	8.43e-05	0.000668	CcSEcCtD
Pentostatin—Feeling abnormal—Leflunomide—systemic scleroderma	8.41e-05	0.000666	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	8.41e-05	0.000666	CcSEcCtD
Pentostatin—Fatigue—Mycophenolic acid—systemic scleroderma	8.4e-05	0.000665	CcSEcCtD
Pentostatin—Mood swings—Methotrexate—systemic scleroderma	8.39e-05	0.000665	CcSEcCtD
Pentostatin—Nausea—Mometasone—systemic scleroderma	8.38e-05	0.000663	CcSEcCtD
Pentostatin—Anorexia—Lisinopril—systemic scleroderma	8.36e-05	0.000662	CcSEcCtD
Pentostatin—Gastrointestinal pain—Leflunomide—systemic scleroderma	8.35e-05	0.000661	CcSEcCtD
Pentostatin—Ataxia—Methotrexate—systemic scleroderma	8.33e-05	0.00066	CcSEcCtD
Pentostatin—Pain—Mycophenolic acid—systemic scleroderma	8.33e-05	0.000659	CcSEcCtD
Pentostatin—Constipation—Mycophenolic acid—systemic scleroderma	8.33e-05	0.000659	CcSEcCtD
Pentostatin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	8.28e-05	0.000655	CcSEcCtD
Pentostatin—Cough—Mycophenolate mofetil—systemic scleroderma	8.22e-05	0.000651	CcSEcCtD
Pentostatin—Hypotension—Lisinopril—systemic scleroderma	8.2e-05	0.000649	CcSEcCtD
Pentostatin—Dizziness—Captopril—systemic scleroderma	8.19e-05	0.000649	CcSEcCtD
Pentostatin—Liver function test abnormal—Methotrexate—systemic scleroderma	8.18e-05	0.000648	CcSEcCtD
Pentostatin—Convulsion—Mycophenolate mofetil—systemic scleroderma	8.16e-05	0.000646	CcSEcCtD
Pentostatin—Depression—Prednisone—systemic scleroderma	8.14e-05	0.000645	CcSEcCtD
Pentostatin—Hypertension—Mycophenolate mofetil—systemic scleroderma	8.13e-05	0.000644	CcSEcCtD
Pentostatin—Urticaria—Leflunomide—systemic scleroderma	8.11e-05	0.000642	CcSEcCtD
Pentostatin—Body temperature increased—Leflunomide—systemic scleroderma	8.07e-05	0.000639	CcSEcCtD
Pentostatin—Abdominal pain—Leflunomide—systemic scleroderma	8.07e-05	0.000639	CcSEcCtD
Pentostatin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	8.02e-05	0.000635	CcSEcCtD
Pentostatin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	8.02e-05	0.000635	CcSEcCtD
Pentostatin—Chest pain—Mycophenolate mofetil—systemic scleroderma	8.02e-05	0.000635	CcSEcCtD
Pentostatin—Myalgia—Mycophenolate mofetil—systemic scleroderma	8.02e-05	0.000635	CcSEcCtD
Pentostatin—Neuropathy peripheral—Prednisone—systemic scleroderma	8.01e-05	0.000634	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.99e-05	0.000633	CcSEcCtD
Pentostatin—Anxiety—Mycophenolate mofetil—systemic scleroderma	7.99e-05	0.000633	CcSEcCtD
Pentostatin—Hypersensitivity—Azathioprine—systemic scleroderma	7.96e-05	0.000631	CcSEcCtD
Pentostatin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.96e-05	0.000631	CcSEcCtD
Pentostatin—Insomnia—Lisinopril—systemic scleroderma	7.93e-05	0.000628	CcSEcCtD
Pentostatin—Paraesthesia—Lisinopril—systemic scleroderma	7.88e-05	0.000624	CcSEcCtD
Pentostatin—Vomiting—Captopril—systemic scleroderma	7.87e-05	0.000624	CcSEcCtD
Pentostatin—Dyspnoea—Lisinopril—systemic scleroderma	7.82e-05	0.000619	CcSEcCtD
Pentostatin—Rash—Captopril—systemic scleroderma	7.81e-05	0.000618	CcSEcCtD
Pentostatin—Dermatitis—Captopril—systemic scleroderma	7.8e-05	0.000618	CcSEcCtD
Pentostatin—Somnolence—Lisinopril—systemic scleroderma	7.8e-05	0.000618	CcSEcCtD
Pentostatin—Headache—Captopril—systemic scleroderma	7.76e-05	0.000614	CcSEcCtD
Pentostatin—Confusional state—Mycophenolate mofetil—systemic scleroderma	7.75e-05	0.000614	CcSEcCtD
Pentostatin—Dyspepsia—Lisinopril—systemic scleroderma	7.72e-05	0.000611	CcSEcCtD
Pentostatin—Body temperature increased—Mycophenolic acid—systemic scleroderma	7.7e-05	0.00061	CcSEcCtD
Pentostatin—Abdominal pain—Mycophenolic acid—systemic scleroderma	7.7e-05	0.00061	CcSEcCtD
Pentostatin—Asthma—Methotrexate—systemic scleroderma	7.66e-05	0.000606	CcSEcCtD
Pentostatin—Infection—Mycophenolate mofetil—systemic scleroderma	7.63e-05	0.000605	CcSEcCtD
Pentostatin—Decreased appetite—Lisinopril—systemic scleroderma	7.62e-05	0.000604	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	7.57e-05	0.0006	CcSEcCtD
Pentostatin—Fatigue—Lisinopril—systemic scleroderma	7.56e-05	0.000599	CcSEcCtD
Pentostatin—Shock—Mycophenolate mofetil—systemic scleroderma	7.56e-05	0.000599	CcSEcCtD
Pentostatin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	7.54e-05	0.000597	CcSEcCtD
Pentostatin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	7.52e-05	0.000596	CcSEcCtD
Pentostatin—Hypersensitivity—Leflunomide—systemic scleroderma	7.52e-05	0.000596	CcSEcCtD
Pentostatin—Constipation—Lisinopril—systemic scleroderma	7.5e-05	0.000594	CcSEcCtD
Pentostatin—Pain—Lisinopril—systemic scleroderma	7.5e-05	0.000594	CcSEcCtD
Pentostatin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	7.5e-05	0.000594	CcSEcCtD
Pentostatin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	7.46e-05	0.000591	CcSEcCtD
Pentostatin—Bradycardia—Prednisone—systemic scleroderma	7.46e-05	0.000591	CcSEcCtD
Pentostatin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	7.43e-05	0.000588	CcSEcCtD
Pentostatin—Diarrhoea—Azathioprine—systemic scleroderma	7.4e-05	0.000586	CcSEcCtD
Pentostatin—Haemoglobin—Prednisone—systemic scleroderma	7.37e-05	0.000584	CcSEcCtD
Pentostatin—Nausea—Captopril—systemic scleroderma	7.36e-05	0.000583	CcSEcCtD
Pentostatin—Haemorrhage—Prednisone—systemic scleroderma	7.33e-05	0.000581	CcSEcCtD
Pentostatin—Anorexia—Mycophenolate mofetil—systemic scleroderma	7.33e-05	0.00058	CcSEcCtD
Pentostatin—Asthenia—Leflunomide—systemic scleroderma	7.32e-05	0.00058	CcSEcCtD
Pentostatin—Hallucination—Prednisone—systemic scleroderma	7.3e-05	0.000578	CcSEcCtD
Pentostatin—Feeling abnormal—Lisinopril—systemic scleroderma	7.23e-05	0.000572	CcSEcCtD
Pentostatin—Pruritus—Leflunomide—systemic scleroderma	7.22e-05	0.000572	CcSEcCtD
Pentostatin—Hypotension—Mycophenolate mofetil—systemic scleroderma	7.18e-05	0.000569	CcSEcCtD
Pentostatin—Gastrointestinal pain—Lisinopril—systemic scleroderma	7.17e-05	0.000568	CcSEcCtD
Pentostatin—Dizziness—Azathioprine—systemic scleroderma	7.15e-05	0.000566	CcSEcCtD
Pentostatin—Upper respiratory tract infection—Methotrexate—systemic scleroderma	7.11e-05	0.000563	CcSEcCtD
Pentostatin—Erectile dysfunction—Methotrexate—systemic scleroderma	7.05e-05	0.000558	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	7e-05	0.000554	CcSEcCtD
Pentostatin—Photosensitivity reaction—Methotrexate—systemic scleroderma	6.99e-05	0.000553	CcSEcCtD
Pentostatin—Asthenia—Mycophenolic acid—systemic scleroderma	6.99e-05	0.000553	CcSEcCtD
Pentostatin—Diarrhoea—Leflunomide—systemic scleroderma	6.98e-05	0.000553	CcSEcCtD
Pentostatin—Urticaria—Lisinopril—systemic scleroderma	6.97e-05	0.000552	CcSEcCtD
Pentostatin—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.95e-05	0.00055	CcSEcCtD
Pentostatin—Abdominal pain—Lisinopril—systemic scleroderma	6.93e-05	0.000549	CcSEcCtD
Pentostatin—Body temperature increased—Lisinopril—systemic scleroderma	6.93e-05	0.000549	CcSEcCtD
Pentostatin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	6.9e-05	0.000546	CcSEcCtD
Pentostatin—Pruritus—Mycophenolic acid—systemic scleroderma	6.89e-05	0.000546	CcSEcCtD
Pentostatin—Vomiting—Azathioprine—systemic scleroderma	6.87e-05	0.000544	CcSEcCtD
Pentostatin—Pneumonia—Methotrexate—systemic scleroderma	6.87e-05	0.000544	CcSEcCtD
Pentostatin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.85e-05	0.000543	CcSEcCtD
Pentostatin—Somnolence—Mycophenolate mofetil—systemic scleroderma	6.83e-05	0.000541	CcSEcCtD
Pentostatin—Rash—Azathioprine—systemic scleroderma	6.82e-05	0.00054	CcSEcCtD
Pentostatin—Dermatitis—Azathioprine—systemic scleroderma	6.81e-05	0.000539	CcSEcCtD
Pentostatin—Depression—Methotrexate—systemic scleroderma	6.81e-05	0.000539	CcSEcCtD
Pentostatin—Headache—Azathioprine—systemic scleroderma	6.77e-05	0.000536	CcSEcCtD
Pentostatin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	6.76e-05	0.000536	CcSEcCtD
Pentostatin—Dizziness—Leflunomide—systemic scleroderma	6.75e-05	0.000535	CcSEcCtD
Pentostatin—Renal failure—Methotrexate—systemic scleroderma	6.71e-05	0.000531	CcSEcCtD
Pentostatin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	6.68e-05	0.000529	CcSEcCtD
Pentostatin—Diarrhoea—Mycophenolic acid—systemic scleroderma	6.66e-05	0.000528	CcSEcCtD
Pentostatin—Stomatitis—Methotrexate—systemic scleroderma	6.65e-05	0.000527	CcSEcCtD
Pentostatin—Conjunctivitis—Methotrexate—systemic scleroderma	6.63e-05	0.000525	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	6.63e-05	0.000525	CcSEcCtD
Pentostatin—Constipation—Mycophenolate mofetil—systemic scleroderma	6.57e-05	0.00052	CcSEcCtD
Pentostatin—Pain—Mycophenolate mofetil—systemic scleroderma	6.57e-05	0.00052	CcSEcCtD
Pentostatin—Arrhythmia—Prednisone—systemic scleroderma	6.55e-05	0.000519	CcSEcCtD
Pentostatin—Sweating—Methotrexate—systemic scleroderma	6.54e-05	0.000518	CcSEcCtD
Pentostatin—Vomiting—Leflunomide—systemic scleroderma	6.49e-05	0.000514	CcSEcCtD
Pentostatin—Alopecia—Prednisone—systemic scleroderma	6.48e-05	0.000513	CcSEcCtD
Pentostatin—Hypersensitivity—Lisinopril—systemic scleroderma	6.46e-05	0.000512	CcSEcCtD
Pentostatin—Dizziness—Mycophenolic acid—systemic scleroderma	6.44e-05	0.00051	CcSEcCtD
Pentostatin—Rash—Leflunomide—systemic scleroderma	6.44e-05	0.00051	CcSEcCtD
Pentostatin—Dermatitis—Leflunomide—systemic scleroderma	6.43e-05	0.000509	CcSEcCtD
Pentostatin—Nausea—Azathioprine—systemic scleroderma	6.42e-05	0.000508	CcSEcCtD
Pentostatin—Headache—Leflunomide—systemic scleroderma	6.39e-05	0.000506	CcSEcCtD
Pentostatin—Agranulocytosis—Methotrexate—systemic scleroderma	6.37e-05	0.000504	CcSEcCtD
Pentostatin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	6.33e-05	0.000502	CcSEcCtD
Pentostatin—Asthenia—Lisinopril—systemic scleroderma	6.29e-05	0.000498	CcSEcCtD
Pentostatin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	6.28e-05	0.000498	CcSEcCtD
Pentostatin—Pruritus—Lisinopril—systemic scleroderma	6.21e-05	0.000491	CcSEcCtD
Pentostatin—Vomiting—Mycophenolic acid—systemic scleroderma	6.19e-05	0.00049	CcSEcCtD
Pentostatin—Haemoglobin—Methotrexate—systemic scleroderma	6.16e-05	0.000488	CcSEcCtD
Pentostatin—Rash—Mycophenolic acid—systemic scleroderma	6.14e-05	0.000486	CcSEcCtD
Pentostatin—Dermatitis—Mycophenolic acid—systemic scleroderma	6.13e-05	0.000486	CcSEcCtD
Pentostatin—Haemorrhage—Methotrexate—systemic scleroderma	6.13e-05	0.000485	CcSEcCtD
Pentostatin—Urticaria—Mycophenolate mofetil—systemic scleroderma	6.1e-05	0.000483	CcSEcCtD
Pentostatin—Headache—Mycophenolic acid—systemic scleroderma	6.1e-05	0.000483	CcSEcCtD
Pentostatin—Pharyngitis—Methotrexate—systemic scleroderma	6.08e-05	0.000482	CcSEcCtD
Pentostatin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	6.07e-05	0.000481	CcSEcCtD
Pentostatin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	6.07e-05	0.000481	CcSEcCtD
Pentostatin—Nausea—Leflunomide—systemic scleroderma	6.06e-05	0.00048	CcSEcCtD
Pentostatin—Diarrhoea—Lisinopril—systemic scleroderma	6e-05	0.000475	CcSEcCtD
Pentostatin—Visual impairment—Methotrexate—systemic scleroderma	5.91e-05	0.000468	CcSEcCtD
Pentostatin—Anaemia—Prednisone—systemic scleroderma	5.9e-05	0.000467	CcSEcCtD
Pentostatin—Agitation—Prednisone—systemic scleroderma	5.87e-05	0.000465	CcSEcCtD
Pentostatin—Dizziness—Lisinopril—systemic scleroderma	5.8e-05	0.000459	CcSEcCtD
Pentostatin—Nausea—Mycophenolic acid—systemic scleroderma	5.78e-05	0.000458	CcSEcCtD
Pentostatin—Vertigo—Prednisone—systemic scleroderma	5.73e-05	0.000454	CcSEcCtD
Pentostatin—Syncope—Prednisone—systemic scleroderma	5.72e-05	0.000453	CcSEcCtD
Pentostatin—Tinnitus—Methotrexate—systemic scleroderma	5.71e-05	0.000452	CcSEcCtD
Pentostatin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.66e-05	0.000448	CcSEcCtD
Pentostatin—Loss of consciousness—Prednisone—systemic scleroderma	5.61e-05	0.000444	CcSEcCtD
Pentostatin—Vomiting—Lisinopril—systemic scleroderma	5.58e-05	0.000442	CcSEcCtD
Pentostatin—Rash—Lisinopril—systemic scleroderma	5.53e-05	0.000438	CcSEcCtD
Pentostatin—Convulsion—Prednisone—systemic scleroderma	5.53e-05	0.000438	CcSEcCtD
Pentostatin—Dermatitis—Lisinopril—systemic scleroderma	5.53e-05	0.000438	CcSEcCtD
Pentostatin—Asthenia—Mycophenolate mofetil—systemic scleroderma	5.51e-05	0.000437	CcSEcCtD
Pentostatin—Hypertension—Prednisone—systemic scleroderma	5.51e-05	0.000436	CcSEcCtD
Pentostatin—Chills—Methotrexate—systemic scleroderma	5.5e-05	0.000435	CcSEcCtD
Pentostatin—Headache—Lisinopril—systemic scleroderma	5.49e-05	0.000435	CcSEcCtD
Pentostatin—Pruritus—Mycophenolate mofetil—systemic scleroderma	5.44e-05	0.000431	CcSEcCtD
Pentostatin—Arthralgia—Prednisone—systemic scleroderma	5.43e-05	0.00043	CcSEcCtD
Pentostatin—Myalgia—Prednisone—systemic scleroderma	5.43e-05	0.00043	CcSEcCtD
Pentostatin—Anxiety—Prednisone—systemic scleroderma	5.42e-05	0.000429	CcSEcCtD
Pentostatin—Alopecia—Methotrexate—systemic scleroderma	5.41e-05	0.000429	CcSEcCtD
Pentostatin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	5.26e-05	0.000416	CcSEcCtD
Pentostatin—Nausea—Lisinopril—systemic scleroderma	5.21e-05	0.000413	CcSEcCtD
Pentostatin—Infection—Prednisone—systemic scleroderma	5.18e-05	0.00041	CcSEcCtD
Pentostatin—Shock—Prednisone—systemic scleroderma	5.12e-05	0.000406	CcSEcCtD
Pentostatin—Nervous system disorder—Prednisone—systemic scleroderma	5.11e-05	0.000405	CcSEcCtD
Pentostatin—Tachycardia—Prednisone—systemic scleroderma	5.08e-05	0.000403	CcSEcCtD
Pentostatin—Dizziness—Mycophenolate mofetil—systemic scleroderma	5.08e-05	0.000402	CcSEcCtD
Pentostatin—Skin disorder—Prednisone—systemic scleroderma	5.06e-05	0.000401	CcSEcCtD
Pentostatin—Hyperhidrosis—Prednisone—systemic scleroderma	5.04e-05	0.000399	CcSEcCtD
Pentostatin—Anorexia—Prednisone—systemic scleroderma	4.97e-05	0.000393	CcSEcCtD
Pentostatin—Anaemia—Methotrexate—systemic scleroderma	4.93e-05	0.00039	CcSEcCtD
Pentostatin—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.89e-05	0.000387	CcSEcCtD
Pentostatin—Rash—Mycophenolate mofetil—systemic scleroderma	4.85e-05	0.000384	CcSEcCtD
Pentostatin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.84e-05	0.000383	CcSEcCtD
Pentostatin—Headache—Mycophenolate mofetil—systemic scleroderma	4.81e-05	0.000381	CcSEcCtD
Pentostatin—Vertigo—Methotrexate—systemic scleroderma	4.79e-05	0.00038	CcSEcCtD
Pentostatin—Leukopenia—Methotrexate—systemic scleroderma	4.77e-05	0.000378	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.75e-05	0.000376	CcSEcCtD
Pentostatin—Insomnia—Prednisone—systemic scleroderma	4.71e-05	0.000373	CcSEcCtD
Pentostatin—Paraesthesia—Prednisone—systemic scleroderma	4.68e-05	0.00037	CcSEcCtD
Pentostatin—Cough—Methotrexate—systemic scleroderma	4.65e-05	0.000369	CcSEcCtD
Pentostatin—Convulsion—Methotrexate—systemic scleroderma	4.62e-05	0.000366	CcSEcCtD
Pentostatin—Dyspepsia—Prednisone—systemic scleroderma	4.59e-05	0.000363	CcSEcCtD
Pentostatin—Nausea—Mycophenolate mofetil—systemic scleroderma	4.56e-05	0.000362	CcSEcCtD
Pentostatin—Myalgia—Methotrexate—systemic scleroderma	4.54e-05	0.00036	CcSEcCtD
Pentostatin—Chest pain—Methotrexate—systemic scleroderma	4.54e-05	0.00036	CcSEcCtD
Pentostatin—Arthralgia—Methotrexate—systemic scleroderma	4.54e-05	0.00036	CcSEcCtD
Pentostatin—Decreased appetite—Prednisone—systemic scleroderma	4.53e-05	0.000359	CcSEcCtD
Pentostatin—Fatigue—Prednisone—systemic scleroderma	4.49e-05	0.000356	CcSEcCtD
Pentostatin—Constipation—Prednisone—systemic scleroderma	4.45e-05	0.000353	CcSEcCtD
Pentostatin—Confusional state—Methotrexate—systemic scleroderma	4.39e-05	0.000348	CcSEcCtD
Pentostatin—Infection—Methotrexate—systemic scleroderma	4.32e-05	0.000343	CcSEcCtD
Pentostatin—Feeling abnormal—Prednisone—systemic scleroderma	4.29e-05	0.00034	CcSEcCtD
Pentostatin—Nervous system disorder—Methotrexate—systemic scleroderma	4.27e-05	0.000338	CcSEcCtD
Pentostatin—Thrombocytopenia—Methotrexate—systemic scleroderma	4.26e-05	0.000338	CcSEcCtD
Pentostatin—Gastrointestinal pain—Prednisone—systemic scleroderma	4.26e-05	0.000337	CcSEcCtD
Pentostatin—Skin disorder—Methotrexate—systemic scleroderma	4.23e-05	0.000335	CcSEcCtD
Pentostatin—Hyperhidrosis—Methotrexate—systemic scleroderma	4.21e-05	0.000333	CcSEcCtD
Pentostatin—Anorexia—Methotrexate—systemic scleroderma	4.15e-05	0.000329	CcSEcCtD
Pentostatin—Urticaria—Prednisone—systemic scleroderma	4.14e-05	0.000328	CcSEcCtD
Pentostatin—Body temperature increased—Prednisone—systemic scleroderma	4.12e-05	0.000326	CcSEcCtD
Pentostatin—Abdominal pain—Prednisone—systemic scleroderma	4.12e-05	0.000326	CcSEcCtD
Pentostatin—Hypotension—Methotrexate—systemic scleroderma	4.07e-05	0.000322	CcSEcCtD
Pentostatin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.97e-05	0.000314	CcSEcCtD
Pentostatin—Insomnia—Methotrexate—systemic scleroderma	3.94e-05	0.000312	CcSEcCtD
Pentostatin—Paraesthesia—Methotrexate—systemic scleroderma	3.91e-05	0.00031	CcSEcCtD
Pentostatin—Dyspnoea—Methotrexate—systemic scleroderma	3.88e-05	0.000307	CcSEcCtD
Pentostatin—Somnolence—Methotrexate—systemic scleroderma	3.87e-05	0.000307	CcSEcCtD
Pentostatin—Hypersensitivity—Prednisone—systemic scleroderma	3.84e-05	0.000304	CcSEcCtD
Pentostatin—Dyspepsia—Methotrexate—systemic scleroderma	3.83e-05	0.000303	CcSEcCtD
Pentostatin—Decreased appetite—Methotrexate—systemic scleroderma	3.78e-05	0.0003	CcSEcCtD
Pentostatin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.76e-05	0.000298	CcSEcCtD
Pentostatin—Fatigue—Methotrexate—systemic scleroderma	3.75e-05	0.000297	CcSEcCtD
Pentostatin—Asthenia—Prednisone—systemic scleroderma	3.74e-05	0.000296	CcSEcCtD
Pentostatin—Pain—Methotrexate—systemic scleroderma	3.72e-05	0.000295	CcSEcCtD
Pentostatin—Pruritus—Prednisone—systemic scleroderma	3.69e-05	0.000292	CcSEcCtD
Pentostatin—Feeling abnormal—Methotrexate—systemic scleroderma	3.59e-05	0.000284	CcSEcCtD
Pentostatin—Diarrhoea—Prednisone—systemic scleroderma	3.56e-05	0.000282	CcSEcCtD
Pentostatin—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.56e-05	0.000282	CcSEcCtD
Pentostatin—Urticaria—Methotrexate—systemic scleroderma	3.46e-05	0.000274	CcSEcCtD
Pentostatin—Dizziness—Prednisone—systemic scleroderma	3.44e-05	0.000273	CcSEcCtD
Pentostatin—Abdominal pain—Methotrexate—systemic scleroderma	3.44e-05	0.000273	CcSEcCtD
Pentostatin—Body temperature increased—Methotrexate—systemic scleroderma	3.44e-05	0.000273	CcSEcCtD
Pentostatin—Vomiting—Prednisone—systemic scleroderma	3.31e-05	0.000262	CcSEcCtD
Pentostatin—Rash—Prednisone—systemic scleroderma	3.28e-05	0.00026	CcSEcCtD
Pentostatin—Dermatitis—Prednisone—systemic scleroderma	3.28e-05	0.00026	CcSEcCtD
Pentostatin—Headache—Prednisone—systemic scleroderma	3.26e-05	0.000258	CcSEcCtD
Pentostatin—Hypersensitivity—Methotrexate—systemic scleroderma	3.21e-05	0.000254	CcSEcCtD
Pentostatin—Asthenia—Methotrexate—systemic scleroderma	3.12e-05	0.000247	CcSEcCtD
Pentostatin—Nausea—Prednisone—systemic scleroderma	3.09e-05	0.000245	CcSEcCtD
Pentostatin—Pruritus—Methotrexate—systemic scleroderma	3.08e-05	0.000244	CcSEcCtD
Pentostatin—Diarrhoea—Methotrexate—systemic scleroderma	2.98e-05	0.000236	CcSEcCtD
Pentostatin—Dizziness—Methotrexate—systemic scleroderma	2.88e-05	0.000228	CcSEcCtD
Pentostatin—Vomiting—Methotrexate—systemic scleroderma	2.77e-05	0.000219	CcSEcCtD
Pentostatin—Rash—Methotrexate—systemic scleroderma	2.74e-05	0.000217	CcSEcCtD
Pentostatin—Dermatitis—Methotrexate—systemic scleroderma	2.74e-05	0.000217	CcSEcCtD
Pentostatin—Headache—Methotrexate—systemic scleroderma	2.73e-05	0.000216	CcSEcCtD
Pentostatin—Nausea—Methotrexate—systemic scleroderma	2.59e-05	0.000205	CcSEcCtD
